Literature DB >> 22204371

Pathophysiology of atherosclerosis: the role of inflammation.

Dimitris Tousoulis1, Anna-Maria Kampoli, Nikolaos Papageorgiou, Emmanuel Androulakis, Charalambos Antoniades, Konstantinos Toutouzas, Christodoulos Stefanadis.   

Abstract

Atherosclerosis is a disease of arteries and is characterized by endothelial dysfunction, vascular inflammation, and the build-up of lipids, cholesterol, calcium, and cellular debris within the intima of the vessel wall. A number of factors commonly characterized as "risk factors" for atherosclerosis have been identified to facilitate the development of atherosclerosis by decreasing NO bioavailability in the vascular endothelium. The serious clinical manifestations of atherosclerosis (including coronary heart disease, stroke, and peripheral vascular disease) augment the need of performing the appropriate diagnostic methods to the patients. The most important diagnostic methods include the usage of biochemical markers and the invasive and non-invasive imaging techniques assessing endothelial function. The main drug categories that have been proved to ameliorate the inflammatory state in atherosclerosis are angiotensin converting enzyme inhibitors/angiotensin receptors blockers, statins, and antioxidants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22204371     DOI: 10.2174/138161211798764843

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  36 in total

Review 1.  Type 2 diabetes and cardiovascular disease: what next?

Authors:  Joshua J Joseph; Sherita Hill Golden
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-04       Impact factor: 3.243

Review 2.  Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis.

Authors:  Simone Marcone; Orina Belton; Desmond J Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  2016-06-17       Impact factor: 4.335

3.  Honaucins A-C, potent inhibitors of inflammation and bacterial quorum sensing: synthetic derivatives and structure-activity relationships.

Authors:  Hyukjae Choi; Samantha J Mascuch; Francisco A Villa; Tara Byrum; Margaret E Teasdale; Jennifer E Smith; Linda B Preskitt; David C Rowley; Lena Gerwick; William H Gerwick
Journal:  Chem Biol       Date:  2012-05-25

4.  Follow-up C-reactive protein level is more strongly associated with outcome in stroke patients than admission levels.

Authors:  Andrea Rocco; Peter A Ringleb; Ulrike Grittner; Christian H Nolte; Alice Schneider; Simon Nagel
Journal:  Neurol Sci       Date:  2015-07-25       Impact factor: 3.307

5.  Effect of walnut oil on hyperglycemia-induced oxidative stress and pro-inflammatory cytokines production.

Authors:  Lucia Laubertová; Katarína Koňariková; Helena Gbelcová; Zdeňka Ďuračková; Ingrid Žitňanová
Journal:  Eur J Nutr       Date:  2014-05-11       Impact factor: 5.614

6.  Analyses of C-Reactive Protein, Endothelial Nitric Oxide Synthase and Interleukin-6 Gene Polymorphisms in Adolescents with a Family History of Premature Coronary Artery Disease: A Pilot Study.

Authors:  Ataç Çelik; Mustafa Özçetin; Ömer Ateş; Fatih Altunkaş; Kayıhan Karaman; İlker Akar; İlker İnce; Murat Yalçın; Metin Karayakalı; Köksal Ceyhan; Fatih Koç
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

7.  Is there an association between sarcoidosis and atherosclerosis?

Authors:  Yusuf Yilmaz; Seref Kul; Murat Kavas; Hayriye Erman; Gonul Aciksari; Fatma Betul Ozcan; Emre Yalcinkaya; Asiye Kanbay; Mustafa Caliskan
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-29       Impact factor: 2.357

8.  Arterial stiffness is increased in asthmatic children.

Authors:  Markus Steinmann; Chiara Abbas; Florian Singer; Carmen Casaulta; Nicolas Regamey; Dieter Haffner; Dagmar-Christiane Fischer; Giacomo D Simonetti
Journal:  Eur J Pediatr       Date:  2014-09-25       Impact factor: 3.183

Review 9.  Impact of nutrients and food components on dyslipidemias: what is the evidence?

Authors:  Carla de Oliveira Barbosa Rosa; Carolina Araújo Dos Santos; Jacqueline Isaura Alvarez Leite; Ana Paula Silva Caldas; Josefina Bressan
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

10.  Bromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways.

Authors:  Mahesh Sapkota; Liang Li; Hyukjae Choi; William H Gerwick; Yunjo Soh
Journal:  Eur J Pharmacol       Date:  2015-11-10       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.